Document is current
Any future updates will be listed below
-
Authors
Freudenberg-Jahn, Kristin
Ben-Horin, Idan
Murali Shankar, Nivedha
Schuldt, Maria
Ortiz-Montero, Paola
Loureiro, Liliana R.
Rackwitz, Wiebke
Opitz, Corinna
Krutz, Lydia
Breither, Thomas
Oberoi, Pranav
Häcker, Aline
Jäger, Dirk
Kuhlmann, Jan Dominik
Wimberger, Pauline
Künzel, Stephan R.
Hölig, Kristina
Feldmann, Anja
Bachmann, Michael
Wels, Winfried S.
Tonn, Torsten
Eitler, Jiri https://orcid.org/0000-0002-3175-2438
-
Funding
Funding for this research was provided by:
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 12 December 2025
Accepted: 27 April 2026
First Online: 19 May 2026
Declarations
:
: The ascites fluid was collected for therapeutic purposes.
: TT, WSW, PO and MB are named as inventors on patents and patent applications in the field of cancer immunotherapy owned by their respective institutions. The other authors declare that they have no competing interests.
